The third quarter of 2010 is going out with a monsoon in New England. It seems like a good time to hole up indoors and look back at some of the top stories we’ve done at Xconomy Boston over the past three months.
These are our editors’ picks. They aren’t necessarily the ones that got the most traffic or the most attention. Rather, they are stories that highlight our unique style of on-the-scene reporting and in-depth analysis, and will stand the test of time. They range from startup profiles in health IT, security software, and drug development, to analysis pieces on leading companies’ acquisition and expansion strategies, to unique venture capital perspectives and quirky, strange-but-true facts about New England innovation leaders.
So, without further ado, here are our top 20 stories of the third quarter, in reverse chronological order (plus a bonus story, in honor of Unica founder Yuchun Lee, a former member of the MIT Blackjack Team, selling his company to IBM for $21 a share):
Genzyme Boss Henri Termeer Not Ready to Sell to Sanofi, Ride Into the Sunset, Sources Say
MeYou Health Enters Social Gaming Realm with Daily Challenge for Improving Well-Being
Bluebird Bio, Third Rock & Genzyme’s Gene Therapy Bet, Shows Promise for Blood Disorder
A123 Opens Lithium Ion Battery Plant in Michigan, Wants to Create Global Hub for Electric Vehicles
Good Start Genetics Emerges from Stealth with $18M Series A Round
Reality Show Project Seeks to Capture MassChallenge Competitors in Their Entrepreneurial Element
Vertex Nails Third Big Trial With Hepatitis C Drug, In Toughest Patients to Treat … Next Page »
By posting a comment, you agree to our terms and conditions.
Oops. Here are a couple more life sciences stories I forgot to remind Greg about. These pieces were about the resveratrol controversy that flared up over a couple days in mid-August.
http://www.xconomy.com/boston/2010/08/12/former-sirtris-execs-nonprofit-starts-selling-resveratrol-with-potential-anti-aging-effects-online/
http://www.xconomy.com/boston/2010/08/13/report-former-sirtris-execs-ordered-to-stop-selling-resveratrol-dietary-supplement-online/